Max Healthcare Institute Ltd share price
Max Healthcare Institute Ltd (MAXHEALTH) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Hospitals / Healthcare theme. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Max Healthcare Institute Limited value chain — customers, suppliers & competitors
Max Healthcare Institute Limited operates a network of super-speciality hospitals and medical centres, providing advanced clinical, surgical, and diagnostic healthcare services directly to patients.
🛒 Customers — who buys from Max Healthcare Institute Limited
- Retail Patients — In-patient and out-patient medical treatments
- Corporate Clients — Corporate health check-ups and employee healthcare packages
- Third-Party Administrators (TPAs) / Insurance — Cashless medical treatments for policyholders
⛓️ Suppliers — raw materials & inputs
- Medical Equipment Manufacturers — Diagnostic and surgical equipment (MRI, CT scanners, surgical tools)
- Pharmaceutical Distributors — Medicines and surgical consumables
- Medical Professionals — Doctor and specialist services
⚔️ Competitors — other sellers
- Apollo Hospitals Enterprise Limited — Competes on hospital bed capacity, clinical talent, and geographic reach across India; larger in overall scale.
- Aster DM Healthcare Limited — Competes regionally in southern and western India for premium healthcare consumers.
🔀 Other suppliers to its customers
- Manipal Hospitals — Major hospital chain competing for the same insured and retail patients.
🤝 Peers that share its suppliers
- Apollo Hospitals Enterprise Limited — Buys similar medical equipment, drugs, and hires top-tier medical specialists.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.